Catherine Thieblemont,Sophie Bernard,Thierry Molina
Catherine Thieblemont
Flora E van Leeuwen,Andrea K Ng
Flora E van Leeuwen
Case report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapy [0.03%]
一例化疗失败后口服缬更昔洛韦治疗有效的原发性渗出性淋巴瘤病例报告
Juan Marquet,Kyra Velazquez-Kennedy,Sandra López et al.
Juan Marquet et al.
Primary effusion lymphoma is a rare non-Hodgkin lymphoma that presents with pleural effusions and lacking of tumour mass. It is universally associated with human herpesvirus 8 (HHV8) and is more frequent among immunosuppressed patients. The...
Case Reports
Hematological oncology. 2018 Feb;36(1):316-319. DOI:10.1002/hon.2445 2018
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement [0.03%]
血管生成素-2通过结合Tie-2受体作为慢性淋巴细胞白血病B细胞的生存因子
Rossana Maffei,Stefania Fiorcari,Silvia Martinelli et al.
Rossana Maffei et al.
Complete remission with romidepsin in a patient with T-cell acute lymphoblastic leukemia refractory to induction hyper-CVAD [0.03%]
一例难治性超剂量CVAD诱导治疗T细胞急性淋巴细胞白血病患者使用罗米地辛后达到完全缓解
Mark W Brunvand,John Carson
Mark W Brunvand
T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) are neoplasms that originate from T-cell precursors. Outcomes in adult patients with T-ALL/LBL remain unsatisfactory; early relapse following intensive in...
Case Reports
Hematological oncology. 2018 Feb;36(1):340-343. DOI:10.1002/hon.2421 2018
Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone [0.03%]
CALR缺失患者中MPLW515突变的出现：CALR克隆继发获得MPL突变的证据
Nicolas Partouche,Carole Conejero,Quentin Barathon et al.
Nicolas Partouche et al.
Myeloproliferative neoplasms are characterized by transduction pathway recognized as mutually exclusive molecular abnormalities such as BCR-ABL translocation, JAK2V617F or JAK2 exon 12 mutations, MPL w515, and CALR mutations. However, in so...
Case Reports
Hematological oncology. 2018 Feb;36(1):336-339. DOI:10.1002/hon.2431 2018
Confocal endomicroscopy in diagnosis of intestinal chronic graft-versus-host disease [0.03%]
共聚焦内镜在肠道慢性移植物抗宿主病诊断中的应用
Kathrin Rieger,Ute Günther,Ulrike Erben et al.
Kathrin Rieger et al.
Graft-versus-host disease (GvHD) is a major complication of allogeneic stem cell transplantation. High-resolution in vivo histology of the intestine by confocal endomicroscopy (CEM) detects acute GvHD (aGvHD) with high sensitivity. This pil...
Are we ready to take full advantage of patient-derived tumor xenograft models? [0.03%]
我们准备好充分运用患者来源的异种移植瘤模型了吗？
Peter W Kyriakides,Giorgio Inghirami
Peter W Kyriakides
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi [0.03%]
非PEG化脂质体多柔比星联合方案治疗伴有心脏合并症的弥漫大B细胞淋巴瘤患者HEART01Ⅱ期试验（Fondazione Italiana Linfomi发起）结果
Stefano Luminari,Elda Viel,Andrés José Maria Ferreri et al.
Stefano Luminari et al.
The purpose of this phase 2, multicenter study was to determine the activity and safety of nonpegylated liposomal doxorubicin as part of "R-COMP" combination in patients with diffuse large B-cell lymphoma and coexisting cardiac disorders. T...
Clinical Trial
Hematological oncology. 2018 Feb;36(1):68-75. DOI:10.1002/hon.2425 2018
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study [0.03%]
JAK抑制剂芦可替尼治疗中危-1(IPSS)期骨髓纤维化患者的疗效和安全性：一项独立研究报告
Francesca Palandri,Mario Tiribelli,Giulia Benevolo et al.
Francesca Palandri et al.
Patients with myelofibrosis at intermediate-1 risk according to the International Prognostic Score System are projected to a relatively long survival; nonetheless, they may carry significant splenomegaly and/or systemic constitutional sympt...